AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,68 USD
arrow_downward
-0,70%(-0,21) 1D
29,68 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 18-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
29,57 USD
High
30,48 USD
Low
29,22 USD
Mkt. cap
1,78 млд
Avg. vol.
1,21 млн
Volume
600,08 миң
52-wk high
44,07 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
29,57 USD
High
30,48 USD
Low
29,22 USD
Mkt. cap
1,78 млд
Avg. vol.
1,21 млн
Volume
600,08 миң
52-wk high
44,07 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
seMissourian
·
45 мүнөт мурун
Fifth straight drop for S&P 500 drags Wall Street to its longest losing streak since June
BeInCrypto
·
1 саат мурун
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
FXStreet
·
4 саат мурун
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
Traders Union
·
4 саат мурун
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc